AnGes, Inc. (4563.T)
Develops gene-based medicines to treat diseases like heart disease and chronic pain.
47.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-36.5%
The outlook
AnGes trades at 47, sitting well below both its 50- and 200-day moving averages and near the bottom of its 52-week range. Analyst coverage appears thin or unavailable. The overall sentiment leans bearish based on current technical positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Market cap
$18.59B
52-wk high
120.00
52-wk low
44.00
50-day avg
47.96
200-day avg
59.43
Trailing P/E
—